Head and neck SCC has previously been mentioned as the next expansion cohort. And melanoma also was hinted at somewhere but I can't find it.
So finalists are:
Head and neck SCC
Bladder
Melanoma
(All advance/metastatic of course).
The conference presentations had 3 expansion indications, so maybe they'll announce more than one over the next 6 months.
.
Ann: Imugene Corporate Presentation, page-32
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.2¢ | 4.9¢ | $531.4K | 10.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3429444 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 149299 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |